Grafnos 1 Capsule
By Grafnos
Rx
10 Capsule in a Strip

Composition
Tacrolimus(1mg)

Manufacturer - Akognos Life Sciences
Corporate & Registered Office, Akognos Life Sciences Pvt. Ltd., Manish Plaza, Third Floor, Plot No. 25, Sector-20 , Dwarka, New Delhi -110075

Expires on or after
August, 2025

liver
When taking Grafnos 1 Capsule, it is important to be cautious if you have liver disease. Patients with liver issues may require adjustments to the dosage of the capsule. It is highly recommended to consult your doctor before using Grafnos 1 Capsule to ensure the appropriate dosage and safety for your liver health.

kidney
Grafnos 1 Capsule requires caution in patients with kidney disease. Dosage adjustment might be necessary. Please consult your doctor.

alcohol
It is not recommended to drink alcohol while taking Grafnos 1 Capsule due to safety concerns.

driving
When taking Grafnos 1 Capsule, be cautious while driving as it may reduce alertness, impact vision, and cause drowsiness or dizziness. Avoid driving if experiencing these symptoms.

pregnancy
Grafnos 1 Capsule could potentially be harmful during pregnancy based on animal studies. Limited human studies are available. Consult your doctor for a personalized assessment considering the risks and benefits before using this medication.

breastfeeding
**Safety Advice - Breastfeeding** Grafnos 1 Capsule is considered unsafe during breastfeeding. Limited data suggests it may pass into breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | Macrolide Lactams |
Therapeutic Class | - |
Action Class | Immunosuppressant- Calcineurin inhibitors |
₹390
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024